Comparison of naftopidil and silodosin in the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia : a randomized, crossover study
We compared the efficacy, safety, and patient preferences for two α1-adrenoceptor (AR) antagonists with different affinity for AR subtypes, naftopidil (Naf) and silodosin (Silo), for the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia (male LUTS/BPH). New...
Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 58(2012), 12 vom: 28. Dez., Seite 671-8 |
---|---|
Auteur principal: | |
Autres auteurs: | , , , |
Format: | Article |
Langue: | Japanese |
Publié: |
2012
|
Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
Sujets: | Clinical Trial Comparative Study English Abstract Journal Article Randomized Controlled Trial Adrenergic alpha-Antagonists Indoles Naphthalenes Piperazines silodosin plus... |